The U.S. Food and Drug Administration blocked a similar successful treatment for mitochondrial disease a quarter of century ...

The evolution of the Prairie Agricultural Machinery Institute will see it looking at how to implement automation, controls ...

PFAS, or forever chemicals, can wreak havoc on the body, disrupting hormones and impacting the immune system. Now, ...

As a researcher, educator and administrator with a knack for making connections, Cynthia Sides has a vision for the Arkansas ...

Lesley Cyford has a job and her husband is a doctor. They might not be able to afford their severely disabled son's care under Trump's Medicaid cuts.

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular ...

The study finds that the organochlorine fungicide Chlorothalonil has adverse developmental and reproductive effects on ...

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...

The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular ...

A trio of scientists at Norwich Research Park have been selected to work on two ground-breaking international research projects.

Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to ...